Recent advances in tumor-targeting anticancer drug conjugates

This publication has 99 references indexed in Scilit:

• Antitumor activity of unsaturated fatty acid esters of 4′-demethyldeoxypodophyllotoxin
  Bioorganic & Medicinal Chemistry Letters, 2003
• DAB₃₈₉IL2 (ONTAK^®) fusion protein therapy of chronic lymphocytic leukaemia
  Expert Opinion on Biological Therapy, 2003
• Inhibition of growth of MDA-MB-231 human breast cancer xenografts in nude mice by bombesin/gastrin-releasing peptide (GRP) antagonists RC-3940-II and RC-3095
  European Journal Of Cancer, 1998
• Inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II
  European Journal Of Cancer, 1997
• Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression
  Current Opinion in Cell Biology, 1994
• Bombesin antagonists inhibit in vitro and in vivo growth of human gastric cancer and binding of bombesin to its receptors
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1994
• Inhibition of growth of MKN45 human gastric‐carcinoma xenografts in nude mice by treatment with bombesin/gastrin‐releasing‐peptide antagonist (RC‐3095) and somatostatin analogue RC‐160
  International Journal of Cancer, 1994
• Hyaluronan receptor-directed assembly of chondrocyte pericellular matrix.
  The Journal of cell biology, 1993
• Potocytosis: Sequestration and Transport of Small Molecules by Caveolae
  Science, 1992
• SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action
  Life Sciences, 1982